RENEO PHARMACEUTICALS INC (RPHM)
US75974E1038 - Common Stock
ChartMill assigns a Buy % Consensus number of 48% to RPHM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.71. This target is 2.31% above the current price.
RPHM was analyzed by 10 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about RPHM.
In the previous month the buy percentage consensus was at a similar level.
RPHM was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-15 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-12-15 | Jefferies | Downgrade | Buy -> Hold |
| 2023-12-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-15 | William Blair | Initiate | Outperform |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | HC Wainwright & Co. | Initiate | Buy |
| 2023-07-03 | B of A Securities | Initiate | Buy |
| 2022-05-18 | Piper Sandler | Maintains | Overweight |
| 2022-01-27 | Baird | Initiate | Outperform |
| 2021-12-21 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-22 | Ladenburg Thalmann | Initiate | Buy |
| 2021-05-04 | SVB Leerink | Initiate | Outperform |
| 2021-05-04 | Piper Sandler | Initiate | Overweight |
| 2021-05-04 | Jefferies | Initiate | Buy |